U.S. President Donald Trump said on Tuesday he intends to impose a "25% or higher" levies on semiconductors and ...

VS Mani, CFO of Glenmark Pharma, discusses the company's strong performance in FY25 with an average of Rs 1,100 crore per ...

Glenmark Pharmaceuticals and FDC Ltd are withdrawing products in the US due to manufacturing problems, as per USFDA reports.

Glenmark Pharmaceuticals reported a net profit of Rs 348 crore for Q3FY25, a significant turnaround from a Rs 351 crore loss ...

Glenmark Pharmaceuticals share price gained more than 5% during intraday trades on Monday post Q3 Results that were declared ...

We expect our North America business to gain momentum from FY26 onwards, supported by our growing respiratory and injectable ...

Glenmark Pharmaceutical Ltd.'s shares rose over 5% during trade on Monday, after the management highlighted a 300.2% sales ...

KR Choksey is bullish on Glenmark Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1768 in ...

Aditya Birla Fashion & Retail and Dish TV will be among 696 firms to release their reports for the Oct-Dec 2024 quarter ...

Glenmark Pharmaceuticals reports strong revenue growth and expansion plans for dermatology and respiratory portfolios in ...

Glenmark Pharmaceuticals Q3 Results 2025:Glenmark Pharmaceuticals declared their Q3 results on 14 Feb, 2025, revealing a ...

Glenmark Pharmaceuticals rose 5.7% after the company reported a 300.2% sales growth in India for the third quarter.